168 related articles for article (PubMed ID: 22326248)
21. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma.
Omagari K; Honda S; Kadokawa Y; Isomoto H; Takeshima F; Hayashida K; Mizuta Y; Murata I; Kohno S
J Gastroenterol Hepatol; 2004 Jul; 19(7):805-11. PubMed ID: 15209629
[TBL] [Abstract][Full Text] [Related]
22. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.
Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM
J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272
[TBL] [Abstract][Full Text] [Related]
24. [Prognosis of hepatocellular carcinoma according to new staging classifications].
Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
[TBL] [Abstract][Full Text] [Related]
25. Treatment and prognostic factors in patients with hepatocellular carcinoma.
Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
[TBL] [Abstract][Full Text] [Related]
26. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
[TBL] [Abstract][Full Text] [Related]
27. LCSGJ-T classification, 6th or 5th edition TNM staging did not independently predict the long-term prognosis of HBV-related hepatocellular carcinoma after radical hepatectomy.
Zhou L; Rui JA; Wang SB; Chen SG; Qu Q
J Surg Res; 2010 Mar; 159(1):538-44. PubMed ID: 19111323
[TBL] [Abstract][Full Text] [Related]
28. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
Farinati F; Rinaldi M; Gianni S; Naccarato R
Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
[TBL] [Abstract][Full Text] [Related]
29. Validation of a new prognostic staging system for hepatocellular carcinoma: a comparison of the biomarker-combined Japan Integrated Staging Score, the conventional Japan Integrated Staging Score and the BALAD Score.
Kitai S; Kudo M; Minami Y; Haji S; Osaki Y; Oka H; Seki T; Kasugai H; Sasaki Y; Matsunaga T
Oncology; 2008; 75 Suppl 1():83-90. PubMed ID: 19092276
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of survival of patients with hepatocellular carcinoma predicted by different staging systems using multivariate analysis.
Nanashima A; Omagari K; Tobinaga S; Shibata K; Sumida Y; Mine M; Morino S; Shibasaki S; Ide N; Shindou H; Nagayasu T
Eur J Surg Oncol; 2005 Oct; 31(8):882-90. PubMed ID: 15993031
[TBL] [Abstract][Full Text] [Related]
31. [Modified CLIP score as a new prognostic index for patients with hepatocellular carcinoma].
Han SH; Han SY; Go BS; Kim MJ; Lee JH; Koo YH; Ryu SH; Cho JH; Jang JS; Lee JH; Roh MH; Choi SR; Choi JC; Lee SW
Korean J Hepatol; 2006 Jun; 12(2):209-20. PubMed ID: 16804346
[TBL] [Abstract][Full Text] [Related]
32. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
33. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
Cho SJ; Yoon JH; Hwang SS; Lee HS
J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220
[TBL] [Abstract][Full Text] [Related]
34. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
[TBL] [Abstract][Full Text] [Related]
36. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
37. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
Chan SL; Mo FK; Johnson PJ; Liem GS; Chan TC; Poon MC; Ma BB; Leung TW; Lai PB; Chan AT; Mok TS; Yeo W
J Gastroenterol Hepatol; 2011 Feb; 26(2):340-7. PubMed ID: 21261725
[TBL] [Abstract][Full Text] [Related]
38. Differential prognostic impact of renal insufficiency on patients with hepatocellular carcinoma: a propensity score analysis and staging strategy.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
J Gastroenterol Hepatol; 2012 Apr; 27(4):690-9. PubMed ID: 22436058
[TBL] [Abstract][Full Text] [Related]
39. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems.
Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y
Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423
[TBL] [Abstract][Full Text] [Related]
40. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
